SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹189 Cr | ₹166 Cr | ₹164 Cr | ₹193 Cr | ₹206 Cr |
What is the latest Total Non-Current Liabilities ratio of SMS PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹189 Cr |
| Mar2024 | ₹166 Cr |
| Mar2023 | ₹164 Cr |
| Mar2022 | ₹193 Cr |
| Mar2021 | ₹206 Cr |
How is Total Non-Current Liabilities of SMS PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹189 Cr | 13.62 | |
| Mar2024 | ₹166 Cr | 1.14 | |
| Mar2023 | ₹164 Cr | -14.82 | |
| Mar2022 | ₹193 Cr | -6.56 | |
| Mar2021 | ₹206 Cr | - | |
Compare Total Non-Current Liabilities of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹3,568.1 Cr | -0.7% | 1.2% | 58% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | -0.7% |
1.2% |
58% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses